# BEIZRAY

NDC: 70710-2092
Generic name: Docetaxel
Labeler / Manufacturer: Zydus Pharmaceuticals USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20251215

FDA application: NDA218711

## Active ingredients

- DOCETAXEL ANHYDROUS: 20 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70710-2092"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70710-2092
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8fb7d980-d6c7-468b-a9f0-adff16101a4b